[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,064,542
  • Shares Outstanding, K 385,873
  • Annual Sales, $ 4,662 M
  • Annual Income, $ 836,300 K
  • EBIT $ 1,033 M
  • EBITDA $ 1,285 M
  • 60-Month Beta 1.45
  • Price/Sales 6.13
  • Price/Cash Flow 26.77
  • Price/Book 9.67

Options Overview Details

View History
  • Implied Volatility 55.97% (+0.94%)
  • Historical Volatility 41.60%
  • IV Percentile 77%
  • IV Rank 56.62%
  • IV High 77.57% on 10/30/25
  • IV Low 27.78% on 08/05/25
  • Expected Move (DTE 1) 1.64 (2.10%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 4,477
  • Volume Avg (30-Day) 2,207
  • Put/Call OI Ratio 0.98
  • Today's Open Interest 83,324
  • Open Int (30-Day) 81,472
  • Expected Range 76.34 to 79.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.61
  • Number of Estimates 9
  • High Estimate $0.64
  • Low Estimate $0.58
  • Prior Year $0.48
  • Growth Rate Est. (year over year) +27.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.30 +15.87%
on 06/30/26
79.15 -1.48%
on 07/16/26
+4.82 (+6.59%)
since 06/16/26
3-Month
56.72 +37.48%
on 04/29/26
79.15 -1.48%
on 07/16/26
+16.75 (+27.36%)
since 04/16/26
52-Week
54.11 +44.11%
on 11/07/25
89.98 -13.34%
on 07/30/25
-6.15 (-7.31%)
since 07/16/25

Most Recent Stories

More News
1 Mid-Cap Stock to Target This Week and 2 We Find Risky

1 Mid-Cap Stock to Target This Week and 2 We Find Risky

AFG : 139.93 (+1.49%)
DXCM : 77.98 (+7.22%)
BIIB : 208.92 (+5.92%)
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Dexcom G7 15 Day is the longest‑lasting and most accurate 1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days ...

DXCM : 77.98 (+7.22%)
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call...

DXCM : 77.98 (+7.22%)
Earnings Preview: What To Expect From DexCom's Report

DexCom is expected to announce its second-quarter earnings soon, and Wall Street expects the company’s EPS to increase by a double-digit percentage.

XLV : 161.80 (+2.22%)
$SPX : 7,533.77 (-0.51%)
DXCM : 77.98 (+7.22%)
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

DXCM : 77.98 (+7.22%)
Patient Monitoring Stocks Q1 Results: Benchmarking DexCom (NASDAQ:DXCM)

Patient Monitoring Stocks Q1 Results: Benchmarking DexCom (NASDAQ:DXCM)

DXCM : 77.98 (+7.22%)
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down

2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down

LKQ : 26.01 (+4.37%)
DXCM : 77.98 (+7.22%)
PFE : 25.14 (+1.29%)
3 Nasdaq 100 Stocks with Promising Prospects

3 Nasdaq 100 Stocks with Promising Prospects

RKLB : 67.35 (-11.61%)
ISRG : 402.33 (+3.43%)
DXCM : 77.98 (+7.22%)
Dexcom Further Advances Vision of Glucose Biosensing for All

At Aspen Ideas: Health, Dexcom announced regulatory milestones, including pediatric clearance for Stelo, further advancing access to glucose biosensing in the United States. The...

DXCM : 77.98 (+7.22%)
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.

TDOC : 9.47 (-2.57%)
NVO : 51.48 (+1.82%)
OZEM : 32.84 (-0.20%)
LLY : 1,169.17 (+1.08%)
DXCM : 77.98 (+7.22%)
OLLI : 66.96 (+2.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 86.41
2nd Resistance Point 82.78
1st Resistance Point 80.38
Last Price 77.98
1st Support Level 74.35
2nd Support Level 70.72
3rd Support Level 68.32

See More

52-Week High 89.98
Last Price 77.98
Fibonacci 61.8% 76.28
Fibonacci 50% 72.04
Fibonacci 38.2% 67.81
52-Week Low 54.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.